BYSI
BeyondSpring Inc.
$1.87
+0.02 (+1.08%)
At close · Jul 2
Market Cap
$76.89M
Shares
41,119,820
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.87
Open$1.88
Day$1.84–1.92
52W$1.18–2.47
Avg vol 30d25K
Short int2.2M · 5.4% float · 137.8d
Short vol36%
Last earningsMay 13, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 13
Equibles Rating
blended score · not investment advice
Overall
Buy
Technical · trend & momentum
Buy
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+10% above
+
Price vs 50-day avg
+17% above
◦
RSI (14)
66 · neutral
+
MACD trend
positive
◦
52-week position
54% · mid-range
Sentiment · smart money
Neutral
◦
Trend (MA cross)
50d $2 › 200d $2 — 200d above 50d
−
Institutional flow
-16% holders QoQ · +5 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
5.36% of float · ▼ -0.4% MoM · 137.8 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
21 holders — mid 3-yr range
Fundamentals
Fair
−
Free cash flow
$-19.8M
+
Balance sheet
net cash $5.6M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Aug 13, 2026
Est · unconfirmed
· in 6 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 13, 2026
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+10% above
Bullish
Price vs 50-day avg
+17% above
Bullish
RSI (14)
66 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
54% · mid-range
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow
Distributing
-16% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
5.36% of float · ▼ -0.4% MoM · 137.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
21 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $1
Now $2 · 54%
52-wk high $2
vs 200-day avg +10%
vs 50-day avg +17%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BYSI
this stock
BeyondSpring Inc.
|
$76.89M | +14.7% | — | — | 5.4% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BYSI | +16.9% | +7.5% | +17.6% | +6.9% | +14.7% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +15.5% | +8.7% | +9.6% | +7.1% | +5.5% |